Incidence of COVID-19 after pulmonary function tests: a retrospective cohort study

Introduction: It has been proposed that exposure to pulmonary function tests (PFT) could be associated with a higher risk of viral transmission. The risk of the Coronavirus Disease 2019 (COVID-19) transmission after performing PFT is unknown. We aimed to assess the incidence  of COVID-19 af...

Descripción completa

Detalles Bibliográficos
Autores principales: Wainstein, Esteban Javier, Peroni, Hector Jose, Ferreyro, Bruno Leonel, Staneloni, Maria Ines, Marcos, Mriam Gabriela, Wolfgor, Alejandro, Aliperti, Valeria Ines, Castro, Horacio Matias
Formato: Artículo revista
Lenguaje:Inglés
Publicado: Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología 2021
Materias:
Acceso en línea:https://revistas.unc.edu.ar/index.php/med/article/view/34351
Aporte de:
id I10-R327-article-34351
record_format ojs
institution Universidad Nacional de Córdoba
institution_str I-10
repository_str R-327
container_title_str Revista de la Facultad de Ciencias Médicas de Córdoba
language Inglés
format Artículo revista
topic COVID-19
SARS-CoV-2
aerosol spray
biosecurity
Respiratory Function Tests
COVID-19
SARS CoV-2
aerosoles
bioseguridad
pruebas de función respiratoria
COVID-19
SARS-CoV-2
aerossóis
contenção de riscos biológicos
Testes de Função Respiratória
spellingShingle COVID-19
SARS-CoV-2
aerosol spray
biosecurity
Respiratory Function Tests
COVID-19
SARS CoV-2
aerosoles
bioseguridad
pruebas de función respiratoria
COVID-19
SARS-CoV-2
aerossóis
contenção de riscos biológicos
Testes de Função Respiratória
Wainstein, Esteban Javier
Peroni, Hector Jose
Ferreyro, Bruno Leonel
Staneloni, Maria Ines
Marcos, Mriam Gabriela
Wolfgor, Alejandro
Aliperti, Valeria Ines
Castro, Horacio Matias
Incidence of COVID-19 after pulmonary function tests: a retrospective cohort study
topic_facet COVID-19
SARS-CoV-2
aerosol spray
biosecurity
Respiratory Function Tests
COVID-19
SARS CoV-2
aerosoles
bioseguridad
pruebas de función respiratoria
COVID-19
SARS-CoV-2
aerossóis
contenção de riscos biológicos
Testes de Função Respiratória
author Wainstein, Esteban Javier
Peroni, Hector Jose
Ferreyro, Bruno Leonel
Staneloni, Maria Ines
Marcos, Mriam Gabriela
Wolfgor, Alejandro
Aliperti, Valeria Ines
Castro, Horacio Matias
author_facet Wainstein, Esteban Javier
Peroni, Hector Jose
Ferreyro, Bruno Leonel
Staneloni, Maria Ines
Marcos, Mriam Gabriela
Wolfgor, Alejandro
Aliperti, Valeria Ines
Castro, Horacio Matias
author_sort Wainstein, Esteban Javier
title Incidence of COVID-19 after pulmonary function tests: a retrospective cohort study
title_short Incidence of COVID-19 after pulmonary function tests: a retrospective cohort study
title_full Incidence of COVID-19 after pulmonary function tests: a retrospective cohort study
title_fullStr Incidence of COVID-19 after pulmonary function tests: a retrospective cohort study
title_full_unstemmed Incidence of COVID-19 after pulmonary function tests: a retrospective cohort study
title_sort incidence of covid-19 after pulmonary function tests: a retrospective cohort study
description Introduction: It has been proposed that exposure to pulmonary function tests (PFT) could be associated with a higher risk of viral transmission. The risk of the Coronavirus Disease 2019 (COVID-19) transmission after performing PFT is unknown. We aimed to assess the incidence  of COVID-19 after a PFT at an academic teaching facility in Buenos Aires, Argentina. Materials and methods: We conducted a retrospective cohort study including all consecutive adult patients that performed PFT between April 1, 2020 and September 30, 2020. Patients with prior COVID-19 were excluded. We defined a 15-day time window to  ascertain PFT related COVID-19. The primary outcome was ascertained by consulting a national database, which has information on all patients with nasopharyngeal swabs for SARS-CoV-2 in Argentina. Results: We included 278 patients who performed a PFT. Fifty percent were women, the mean age was 54 years (SD 18), and the main comorbidities were obesity (31%), smoking (31%), hypertension (29%), and chronic lung disease (28%). The main indication for performing PFT was anesthetic preoperative risk assessment. Swabs were collected from 27 patients (10%). Twenty-two swabs (8%) were taken according to surgical protocols; five swabs (2%) were taken due to clinical suspicion of COVID-19, with only one testing positive. The cumulative incidence of COVID-19 after PFT was 0.36% (95% CI 0.01-20%). None of the technicians developed symptomatic disease. Conclusion: Given the right setting and strict adherence to international recommendations, the SARS-CoV-2 infection after having a PFT appears to be low, which follows that these procedures can be performed safely for both patients and staff.
publisher Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología
publishDate 2021
url https://revistas.unc.edu.ar/index.php/med/article/view/34351
work_keys_str_mv AT wainsteinestebanjavier incidenceofcovid19afterpulmonaryfunctiontestsaretrospectivecohortstudy
AT peronihectorjose incidenceofcovid19afterpulmonaryfunctiontestsaretrospectivecohortstudy
AT ferreyrobrunoleonel incidenceofcovid19afterpulmonaryfunctiontestsaretrospectivecohortstudy
AT stanelonimariaines incidenceofcovid19afterpulmonaryfunctiontestsaretrospectivecohortstudy
AT marcosmriamgabriela incidenceofcovid19afterpulmonaryfunctiontestsaretrospectivecohortstudy
AT wolfgoralejandro incidenceofcovid19afterpulmonaryfunctiontestsaretrospectivecohortstudy
AT alipertivaleriaines incidenceofcovid19afterpulmonaryfunctiontestsaretrospectivecohortstudy
AT castrohoraciomatias incidenceofcovid19afterpulmonaryfunctiontestsaretrospectivecohortstudy
AT wainsteinestebanjavier incidenciadecovid19posteriorarealizarpruebasdefuncionrespiratoriasestudiodecohorteretrospectivo
AT peronihectorjose incidenciadecovid19posteriorarealizarpruebasdefuncionrespiratoriasestudiodecohorteretrospectivo
AT ferreyrobrunoleonel incidenciadecovid19posteriorarealizarpruebasdefuncionrespiratoriasestudiodecohorteretrospectivo
AT stanelonimariaines incidenciadecovid19posteriorarealizarpruebasdefuncionrespiratoriasestudiodecohorteretrospectivo
AT marcosmriamgabriela incidenciadecovid19posteriorarealizarpruebasdefuncionrespiratoriasestudiodecohorteretrospectivo
AT wolfgoralejandro incidenciadecovid19posteriorarealizarpruebasdefuncionrespiratoriasestudiodecohorteretrospectivo
AT alipertivaleriaines incidenciadecovid19posteriorarealizarpruebasdefuncionrespiratoriasestudiodecohorteretrospectivo
AT castrohoraciomatias incidenciadecovid19posteriorarealizarpruebasdefuncionrespiratoriasestudiodecohorteretrospectivo
AT wainsteinestebanjavier incidenciadecovid19apostestesdefuncaopulmonarumestudodecoorteretrospectivo
AT peronihectorjose incidenciadecovid19apostestesdefuncaopulmonarumestudodecoorteretrospectivo
AT ferreyrobrunoleonel incidenciadecovid19apostestesdefuncaopulmonarumestudodecoorteretrospectivo
AT stanelonimariaines incidenciadecovid19apostestesdefuncaopulmonarumestudodecoorteretrospectivo
AT marcosmriamgabriela incidenciadecovid19apostestesdefuncaopulmonarumestudodecoorteretrospectivo
AT wolfgoralejandro incidenciadecovid19apostestesdefuncaopulmonarumestudodecoorteretrospectivo
AT alipertivaleriaines incidenciadecovid19apostestesdefuncaopulmonarumestudodecoorteretrospectivo
AT castrohoraciomatias incidenciadecovid19apostestesdefuncaopulmonarumestudodecoorteretrospectivo
first_indexed 2024-09-03T21:02:37Z
last_indexed 2024-09-03T21:02:37Z
_version_ 1809210259581960192
spelling I10-R327-article-343512021-12-30T12:00:48Z Incidence of COVID-19 after pulmonary function tests: a retrospective cohort study Incidencia de COVID-19 posterior a realizar pruebas de función respiratorias: estudio de cohorte retrospectivo Incidência de COVID-19 após testes de função pulmonar: um estudo de coorte retrospectivo Wainstein, Esteban Javier Peroni, Hector Jose Ferreyro, Bruno Leonel Staneloni, Maria Ines Marcos, Mriam Gabriela Wolfgor, Alejandro Aliperti, Valeria Ines Castro, Horacio Matias COVID-19 SARS-CoV-2 aerosol spray biosecurity Respiratory Function Tests COVID-19 SARS CoV-2 aerosoles bioseguridad pruebas de función respiratoria COVID-19 SARS-CoV-2 aerossóis contenção de riscos biológicos Testes de Função Respiratória Introduction: It has been proposed that exposure to pulmonary function tests (PFT) could be associated with a higher risk of viral transmission. The risk of the Coronavirus Disease 2019 (COVID-19) transmission after performing PFT is unknown. We aimed to assess the incidence  of COVID-19 after a PFT at an academic teaching facility in Buenos Aires, Argentina. Materials and methods: We conducted a retrospective cohort study including all consecutive adult patients that performed PFT between April 1, 2020 and September 30, 2020. Patients with prior COVID-19 were excluded. We defined a 15-day time window to  ascertain PFT related COVID-19. The primary outcome was ascertained by consulting a national database, which has information on all patients with nasopharyngeal swabs for SARS-CoV-2 in Argentina. Results: We included 278 patients who performed a PFT. Fifty percent were women, the mean age was 54 years (SD 18), and the main comorbidities were obesity (31%), smoking (31%), hypertension (29%), and chronic lung disease (28%). The main indication for performing PFT was anesthetic preoperative risk assessment. Swabs were collected from 27 patients (10%). Twenty-two swabs (8%) were taken according to surgical protocols; five swabs (2%) were taken due to clinical suspicion of COVID-19, with only one testing positive. The cumulative incidence of COVID-19 after PFT was 0.36% (95% CI 0.01-20%). None of the technicians developed symptomatic disease. Conclusion: Given the right setting and strict adherence to international recommendations, the SARS-CoV-2 infection after having a PFT appears to be low, which follows that these procedures can be performed safely for both patients and staff. Introducción: Se ha propuesto que las pruebas de función respiratorias (PFR) podrían estar asociadas con un mayor riesgo de transmisión viral. El riesgo de presentar la enfermedad por coronavirus 2019 (COVID-19) después de realizar una PFR es desconocido. El objetivo del estudio fue estimar la incidencia de COVID-19 después de llevar a cabo una PFR, en un Hospital Universitario de la ciudad Autónoma de Buenos Aires, Argentina.  Se realizó una cohorte retrospectiva que incluyó a todos los pacientes que realizaron una PFR entre el 1 de abril de 2020 y el 30 de septiembre de 2020. Se excluyeron los pacientes con antecedentes de COVID-19. Definimos una ventana de tiempo de 15 días para determinar la presencia de COVID-19 relacionada con la realización de la PFR. El resultado primario se determinó consultando una base de datos nacional, que contiene información sobre todos los pacientes que se han realizado hisopados nasofaríngeos para detección del  SARS-CoV-2 en Argentina. Materiales y métodos: Se incluyeron 278 pacientes, el 50% fueron mujeres, el promedio de edad fue de 54 años (DE 18) y las principales comorbilidades fueron: obesidad (31%), tabaquismo (31%), hipertensión (29%) y enfermedades respiratorias crónicas (28%). La principal indicación de la PFR fue la evaluación pre operatoria o anestésica.  A 27 pacientes (10%) se les realizó un hisopado nasofaríngeo para búsqueda de SARS-CoV-2. Veintidós hisopados (8%) se solicitaron por evaluación pre quirúrgica, cinco hisopados (2%) por sospecha clínica de infección y solamente uno fue positivo. La incidencia de COVID-19 fue de 0.36% (IC95% 0.01-20%). Durante el período del estudio ninguno de los operadores que realizaron las PFR presentaron síntomas compatibles con COVID-19. Conclusión: Siguiendo las recomendaciones internacionales, la frecuencia de detección de COVID-19 después de las PFR parece ser bajo, por lo que estos procedimientos se podrían llevar a cabo de forma segura tanto para los pacientes como para el personal.   Introdução: Foi proposto que os testes de função respiratória (TFR) poderiam estar associados a um risco aumentado de transmissão viral. O risco de desenvolver doença coronavírus 2019 (COVID-19) após a realização de um TFR é desconhecido. O objetivo do estudo foi estimar a incidência do COVID-19 após a realização de uma TFR, em um Hospital Universitário da Cidade Autônoma de Buenos Aires, Argentina. Materiais e métodos: Foi realizada uma coorte retrospectiva que incluiu todos os pacientes submetidos a TFR entre 1º de abril de 2020 e 30 de setembro de 2020. Pacientes com história de COVID-19 foram excluídos. Definimos uma janela de tempo de 15 dias para determinar a presença de COVID-19 relacionada ao desempenho do TFR. O desfecho primário foi determinado por consulta a um banco de dados nacional, que contém informações sobre todos os pacientes que fizeram swabs nasofaríngeos para detecção de SARS-CoV-2 na Argentina. Resultados: Foram incluídos 278 pacientes, 50% eram mulheres, a idade média foi de 54 anos (DP 18) e as principais comorbidades foram: obesidade (31%), tabagismo (31%), hipertensão (29%) e doenças respiratórias crônicas (28%). A principal indicação de TFR foi a avaliação pré-operatória ou anestésica. 27 pacientes (10%) foram submetidos a swab nasofaríngeo para pesquisa de SARS-CoV-2. Foram solicitados 22 swabs (8%) para avaliação pré-cirúrgica, cinco swabs (2%) para suspeita clínica de infecção e apenas um foi positivo. A incidência de COVID-19 foi de 0,36% (IC 95% 0,01-20%). Durante o período do estudo, nenhum dos operadores que realizaram o TFR apresentou sintomas compatíveis com COVID-19. Conclusão: Seguindo as recomendações internacionais, a taxa de detecção de COVID-19 após PFRs parece ser baixa, de modo que esses procedimentos podem ser realizados com segurança para pacientes e equipe. Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología 2021-12-28 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion text texto texto application/pdf text/html https://revistas.unc.edu.ar/index.php/med/article/view/34351 10.31053/1853.0605.v78.n4.34351 Revista de la Facultad de Ciencias Médicas de Córdoba.; Vol. 78 No. 4 (2021); 367-370 Revista de la Facultad de Ciencias Médicas de Córdoba; Vol. 78 Núm. 4 (2021); 367-370 Revista da Faculdade de Ciências Médicas de Córdoba; v. 78 n. 4 (2021); 367-370 1853-0605 0014-6722 10.31053/1853.0605.v78.n4 eng https://revistas.unc.edu.ar/index.php/med/article/view/34351/36206 https://revistas.unc.edu.ar/index.php/med/article/view/34351/35974 Derechos de autor 2021 Universidad Nacional de Córdoba http://creativecommons.org/licenses/by-nc/4.0